cerrar

TWi Pharmaceuticals, Taiwan

Last updated: 13.02.2014

twi-logo-1.jpgInnovation, Integrity and Integration
TWi Pharmaceuticals, Inc. headquartered in Taipei, Taiwan, is an emerging specialty pharmaceutical company focusing on the development, manufacturing and commercialization of high barrier generic prescription products, and new drug products that will fulfill unmet medical needs.
Established in April, 2010 as a result of spin-off by Anchen Inc. of the United States, TWi Pharmaceuticals, formerly Anchen Pharmaceuticals (Taiwan), Inc., was the research and development center and manufacturing base of Anchen Inc. in Taiwan. After the spin-off, TWi Pharmaceuticals maintains close relationships with Anchen Inc. and its subsidiary, Anchen Pharmaceuticals, Inc. in Irvine California, USA.
TWi Pharmaceuticals led by a team of dedicated and experienced managers and professionals who have had long and successful career in generic and brand pharmaceutical companies in United States and Asia. Prior to spin-off, TWi Pharmaceuticals using its highly innovative technologies of drug delivery and formulation developed in its Neihu R&D center has contributed in more than 20 Abbreviated New Drug Application (ANDA) submissions accepted by US FDA. Among the ANDA submissions, fifteen are filed with paragraph IV certification including five first to file that indicates no infringement of corresponding brand products and potential market exclusivity. Build upon the accomplishments, TWi Pharmaceuticals is targeting to file and obtain more ANDAs of high barrier generic drugs for US market. In addition, TWi Pharmaceuticals has obtained eight marketing approvals for Taiwan market.

4F, No. 41, Lane 221,
Kanh Chien Rd., Nei Hu Dist.
Taipei 114, Taiwan

Tel: 886-2-26573350
Fax: 886-2-26573391
E-mail: info@twipharma.com

http://www.twipharma.com/index.htm

Interviews

Interview: Calvin Chen, President, TWi Pharmaceuticals, Taiwan

Dr. Chen, you joined US-based Anchen Pharmaceuticals in 2009 to help the company form a spin-off in Taiwan. Why did a US-based company look to establish itself in Taiwan, and…

Related

Interview with Albert Liou, Corporate Vice President & General Manager,…

Unlike many multinational CROs, PAREXEL decided to base its Asia Pacific operations in Taipei instead of Singapore. To what extent was this decision a result of Taiwan’s business environment and…

Interview with Thomas Willemsen, Vice President and General Manager, GSK Taiwan

Please tell our readers about the importance of GSK Taiwan within the context of the company’s global operations, and also what there is in Taiwan that makes it so attractive…

Interview with Warren Chen, Country Manager, Celgene Taiwan

Could you please give our readers an overview of the importance of Taiwan for Celgene in a regional and a global context? What is attractive in Taiwan for Celgene? Celgene…

Interview with Eric Wang, General Manager, Novo Nordisk Taiwan

Novo Nordisk is one of the few pharmaceutical multinationals focused in one key therapeutic area. Perhaps you could start by telling our readers about how diabetes has evolved in Taiwan…

Interview with Stanley Chang, Chairman & CEO, Medigen Biotechnology Corp.

Medigen was created in 1999 and is a listed company. How did the vision for the company come about, and what was it that attracted today’s main shareholders to Medigen?…

Interview with Jen Chen, General Manager, Genovate

Genovate was founded in 1995. It is a very interesting story: a mix of biotech, the history with American company Genelabs, government investments and also private investment through Chinachem. Can…

Interview with Carol Cheng, , IRPMA (International Research-Based Pharmaceutical…

Please describe the activities of the IRPMA to our readers, and explain the membership advantages of your association. Today the IRPMA consists of 37 multinational research-based pharmaceutical manufacturers, as well…

Interview with Jeff Wang, President, Development Center for Biotechnology

The Development Centre for Biotechnology was founded in 1984 as a tool for connecting biotechnological academia to the Taiwanese industry and promoting the strengths of Taiwan’s biopharmaceutical sector to the…

Interview with Mei-Hua Wang, , Taiwan Intellectual Property Office

Please explain the factors that led to the creation of the Taiwan Intellectual Property Office, and its main activities today. For the Taiwanese government, intellectual property (IP) rights are very…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here